Rocuronium Bromide (rocuronium bromide)
Rocuronium Bromide — rocuronium bromide
Rocuronium Bromide 100 mg/10mL · injection · intravenous · Nondepolarizing Neuromuscular Blocker
Source: FDA National Drug Code Directory via openFDA · pulled Sep 23, 2026, 11:50 PM UTC
What the pharmacy actually pays
NADAC is the pharmacy's acquisition cost per unit — not your copay, not the retail price. The gap between NADAC and what you are charged is dispensing fee + markup + PBM spread.
Adverse-event reports to the FDA
FAERS reports are voluntary and unverified; a report does not establish that the drug caused the event. Report volume also rises with how many people take a drug.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA
Type the NDC printed on the package (for example 0093-3109-01) to see the FDA entries for that exact product and maker.
Is it recalled? (last 24 months)
FDA Enforcement Reports via openFDA ↗- Class IIreported 2025-04-30 · Ongoing · Denver Solutions, LLC DBA Leiters Health
Middle level. FDA's definition: use may cause temporary or medically reversible health problems, or the chance of serious harm is remote. Pharmacies pull stock; they are not required to call you. Check your lot number.
Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11
Reason: Lack of Assurance of Sterility: Leaking/damaged syringes.
Lot numbers: Lot #:2530023, Exp.: 7/12/2025
Distribution: Nationwide in the U.S.A · FDA enforcement report ↗
Is it in shortage right now?
FDA Drug Shortages Database via openFDA ↗- 26 current FDA shortage listings for this medicine — by manufacturer and form:
- • Meitheal Pharmaceuticals, Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) · since 02/15/2023 · updated 08/27/2026 · Available
- • Fresenius Kabi USA, LLC · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) · since 02/15/2023 · updated 09/15/2026 · Available
- • Eugia US LLC · Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) · since 02/15/2023 · updated 09/17/2026 · Available
- • Mylan Institutional, a Viatris Company · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) · since 02/15/2023 · updated 09/17/2026 · Available
- • Baxter Healthcare · Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) · since 02/15/2023 · updated 09/17/2026 · Available
- • Fresenius Kabi USA, LLC · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) · since 02/15/2023 · updated 09/15/2026 · Available
- • Meitheal Pharmaceuticals, Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) · since 02/15/2023 · updated 08/27/2026 · Available
- • Fresenius Kabi USA, LLC · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) · since 02/15/2023 · updated 09/15/2026 · reason: Delay in shipping of the drug · Unavailable
- • Mylan Institutional, a Viatris Company · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) · since 02/15/2023 · updated 09/17/2026 · Available
- • Sandoz Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) · since 02/15/2023 · updated 09/18/2026 · Available
- • XGen Pharmaceuticals DJB, Inc. · Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) · since 02/15/2023 · updated 09/22/2026 · Available
- • Fresenius Kabi USA, LLC · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) · since 02/15/2023 · updated 09/15/2026 · reason: Delay in shipping of the drug · Unavailable
- • XGen Pharmaceuticals DJB, Inc. · Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) · since 02/15/2023 · updated 09/22/2026 · Available
- • Baxter Healthcare · Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) · since 02/15/2023 · updated 09/17/2026 · Available
- • Hospira, Inc., a Pfizer Company · Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) · since 02/15/2023 · updated 09/09/2026 · Available
- • Hikma Pharmaceuticals USA, Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) · since 02/15/2023 · updated 09/18/2026 · Available
- • Hospira, Inc., a Pfizer Company · Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) · since 02/15/2023 · updated 09/09/2026 · Available
- • Sagent Pharmaceuticals · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) · since 02/15/2023 · updated 09/18/2026 · Available
- • Sandoz Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) · since 02/15/2023 · updated 09/18/2026 · Available
- • Piramal Critical Care Inc. · Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) · since 02/15/2023 · updated 09/15/2026 · reason: Demand increase for the drug · Limited Availability
- • Fresenius Kabi USA, LLC · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) · since 02/15/2023 · updated 09/15/2026 · Available
- • Eugia US LLC · Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) · since 02/15/2023 · updated 09/17/2026 · Available
- • Hospira, Inc., a Pfizer Company · Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) · since 02/15/2023 · updated 09/09/2026 · Available
- • Hikma Pharmaceuticals USA, Inc. · Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) · since 02/15/2023 · updated 09/18/2026 · Available
- • Hospira, Inc., a Pfizer Company · Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) · since 02/15/2023 · updated 09/09/2026 · Available
Does the label carry a boxed warning?
FDA drug label (SPL) via openFDA ↗No
A boxed warning is the FDA's strongest label warning (21 CFR 201.57(c)(1)). It means the FDA requires the maker to highlight a serious risk — it does not mean the medicine is unsafe for you; it means the risk must be weighed with your prescriber.
Who makes it (labelers listed with the FDA)
FDA National Drug Code Directory via openFDA (labeler names verbatim) ↗Aspen Oss B.V. · B. Braun Medical Inc. · BE Pharmaceuticals Inc. · Baxter Healthcare Corporation · Caplin Steriles Limited · Civica, Inc. · Curia Italy S.r.l · Curia Italy S.r.l. · Curia Spain S.A.U. · Eugia US LLC · Farmhispania S.A. · Farmhispania, S.A. · Fresenius Kabi USA, LLC · Gland Pharma Limited · HF Acquisition Co LLC, DBA HealthFirst · HF Acquisition Co. LLC, DBA HealthFirst · Hikma Pharmaceuticals USA Inc. · Hospira, Inc. · Lifestar Pharma LLC · Mankind Pharma Limited · Medical Purchasing Solutions, LLC · Meitheal Pharmaceuticals Inc. · Mylan Institutional LLC · Pharma Source Direct, Inc. · Phlow Corporation · ProPharma Distribution · STERISCIENCE SPECIALTIES PRIVATE LIMITED · Sagent Pharmaceuticals · Sandoz Inc · Shandong New Time Pharmaceutical Co., Ltd. · Sicor de Mexico S.A. de C.V · Solco Healthcare US, LLC · Wavelength Enterprises LTD · XGen Pharmaceuticals DJB, Inc. · ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. · Zhejiang Xianju Pharmaceutical Co., Ltd.
Checking this medicine for someone you look after
FDA — Understanding drug recalls ↗- Find the lot number. It is printed on the bottle, box, blister pack or pharmacy label, usually near the expiration date, and often starts with 'Lot' or 'L'.
- Compare it with the lot numbers listed on each recall below. Recalls are for specific lots, not every bottle of that medicine.
- If a lot matches: do not stop the medicine on your own. Call the pharmacy that filled it (their number is on the label) or the prescriber and ask what to do. Stopping some medicines suddenly is more dangerous than the recall.
- If no lot matches: the recall does not apply to the medicine you have.
- A shortage is not a safety problem with the medicine itself. It means supply is short. If your pharmacy cannot fill it, ask about an alternative strength, form or manufacturer, and ask the prescriber before switching.
Official FDA records shown verbatim, not medical advice. Never stop or change a medicine without asking the pharmacist or prescriber.
Want an email the day this medicine is recalled, enters shortage or its label changes? Add it to your free family cabinet → · Print a medicine card for the sitter ↗
Three questions to ask before you fill it
- Is there a therapeutically equivalent generic, and if not, why this brand?
- What does the pharmacy actually pay for this (NADAC) versus what I'm being charged?
- Has the manufacturer of this drug paid you or this practice in the last year? (Open Payments is public.)
Official records, not medical advice. Do not change any medication without talking to your prescriber and pharmacist.
Every figure above is an official public record with its source named. Records are records: complaints are not findings, payments are disclosed and legal, adverse-event reports are unverified. Not medical, legal, or financial advice. Nothing here can be changed by payment. How we source this →